anti-HER2 single-chain Fv dimer-deBouganin ADC (Sesen Bio/AviPep)

N/A

Report date: 2025/03/14 16:35:18

Base Information

Drug Nameanti-HER2 single-chain Fv dimer-deBouganin ADC (Sesen Bio/AviPep)
Drug Alias Nameanti-HER2 single-chain Fv dimer-deBouganin ADC (Eleven Bio/AviPep)anti-HER2 single-chain Fv dimer-deBouganin ADC (Viventia/AviPep)deBouganin-C6.5-diabody ADC (Viventia/AviPep)anti-HER2 single-chain Fv dimer-deBouganin antibody drug conjugate (Viventia/AviPep)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViventia Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesSesen Bio IncAvipep
Inactive CompaniesViventia Bio Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A